A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial

BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Anaesth
Main Authors: Sudheesh, K, Chethana, GM, Chaithali, H, Nethra, SS, Devikarani, D, Shwetha, G
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer - Medknow 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://ncbi.nlm.nih.gov/pubmed/31391619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ija.IJA_269_19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados